[Congressional Record Volume 167, Number 21 (Thursday, February 4, 2021)]
[Senate]
[Page S527]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 730. Mr. RISCH submitted an amendment intended to be proposed by 
him to the concurrent resolution S. Con. Res. 5, setting forth the 
congressional budget for the United States Government for fiscal year 
2021 and setting forth the appropriate budgetary levels for fiscal 
years 2022 through 2030; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO EXPANDING 
                   GLOBAL AVAILABILITY AND ACCESS TO VACCINES FOR 
                   THE CORONAVIRUS 2019.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to the 
     expansion of global availability and access to vaccines for 
     the Coronavirus 2019 (COVID-19), which may include providing 
     vaccines to key allies and withholding or conditioning United 
     States participation in COVAX pending certification that 
     COVAX will not accept, procure, or distribute Chinese origin 
     vaccines with substandard reliability, by the amounts 
     provided in such legislation for those purposes, provided 
     that such legislation would not increase the deficit over 
     either the period of the total of fiscal years 2021 through 
     2025 or the period of the total of fiscal years 2021 through 
     2030.
                                 ______